Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SRPT

Recent news which mentions SRPT

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
SRPT Stock Earnings: Sarepta Therapeutics Beats EPS, Beats Revenue for Q1 2024
Tickers SRPT
Tags Earnings Reports SRPT NASDAQ:SRPT
From InvestorPlace
Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
Tickers SRPT
Tags SRPT Market News Recent Press Releases
From Motley Fool
1 Top Growth Stock to Buy and Hold for 10 Years
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in April
Tickers AMGN SRPT
Tags AMGN SRPT Market News
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Tickers CI ITCI JANX JNJ
Tags JANX JNJ Benzinga
From Benzinga
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
Tickers RGNX SRPT
Tags RGNX Recent Press Releases Market News
From Motley Fool
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
Tickers NEWS PFE RGNX SRPT
Tags News Upgrades Analyst Color
From Benzinga
Got $1,000? Buy These Hot Growth Stocks Before They Take Off.
Tickers ENPH GOOG GOOGL SRPT
Tags GOOG SRPT Market News
From Motley Fool
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
Sarepta Therapeutics: Q4 Earnings Insights
Tickers SRPT
Tags Earnings Benzinga Market News
From Benzinga
Is It Too Late to Buy Sarepta Therapeutics Stock?
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
Earnings Scheduled For February 28, 2024
Tickers NOVT NRG NSA NTNX
Tags NVAX SHLS TIPT
From Benzinga
A Preview Of Sarepta Therapeutics's Earnings
Tickers SRPT
Tags Benzinga Earnings BZI/EP
From Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
Tickers CRSP NEWS REGN SRPT
Tags News REGN General
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ARQT IOVA LLY MDT
Tags NVO Benzinga PFE
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers AMIX AMN AORT BCLI
Tags CLDI AMN SXTC
From Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
Tickers NEWS RHHBY SRPT
Tags why it's moving Analyst Ratings Biotech
From Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tickers AMAT AMBO AMN AORT
Tags ROKU HOLO TCTM
From Benzinga
Why Sarepta Therapeutics Stock Is Soaring Today
Tickers SRPT
Tags SRPT Recent Press Releases Market News
From Motley Fool
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
Tickers AMAT AORT BIO BLZE
Tags HRT TTD SWAV
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tickers AMN AORT CDIO HCTI
Tags IKNA BZI/TFM Benzinga
From Benzinga
In-Depth Examination Of 13 Analyst Recommendations For Sarepta Therapeutics
Tickers SRPT
Tags SRPT BZI/AAR Market News
From Benzinga
2 Magnificent Growth Stocks to Buy With $500
Tickers SRPT VEEV
Tags VEEV SRPT Market News
From Motley Fool
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
Tickers DNLI NEWS PFE RGNX
Tags Market News SRPT Price Target
From Benzinga
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
Tickers PTCT SRPT
Tags Market News PTCT Recent Press Releases
From Motley Fool
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
Tickers ADP AJG AMGN AMH
Tags MA ILMN HAL
From InvestorPlace
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
Tickers SRPT
Tags SRPT Analyst Ratings Benzinga
From Benzinga
Sarepta Therapeutics' Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing
Tickers NEWS SRPT
Tags Briefs General Health Care
From Benzinga
Got $3,000? 3 Growth Stocks to Double Up On Right Now
Tickers SRPT SYM UBER
Tags Market News Recent Press Releases SYM
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.